Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Chen, Jianwei ^a   Liu, Zude ^a   Zhong, Guibin ^a   Qian, Lie ^a   Li, Zhanchun ^a   Qiao, Zhiguang ^b   Chen, Bin ^a   Wang, Hantao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTIN; MESSENGER RNA; MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELASTIC FIBER; FEMALE; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LAMINECTOMY; LIGAMENT DISEASE; LIGAMENTUM FLAVUM HYPERTROPHY; LUMBAR DISK HERNIA; LUMBAR SPINAL STENOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THICKNESS; CASE CONTROL STUDY; CELL CULTURE; GENETICS; HYPERTROPHY; LIGAMENTUM FLAVUM; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION; VERTEBRAL CANAL STENOSIS; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; ELASTIN; FEMALE; FIBROSIS; GENE EXPRESSION; HUMANS; HYPERTROPHY; LIGAMENTUM FLAVUM; LUMBAR VERTEBRAE; MALE; MICRORNAS; MIDDLE AGED; PROTEOLYSIS; SPINAL STENOSIS; UP-REGULATION; YOUNG ADULT;

EID: 84902128748     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/786543     Document Type: Article

References (34)

1. Englund J., Lumbar spinal stenosis. Current Sports Medicine Reports 2007 6 1 50 55 2-s2.0-33846995697 10.1007/s11932-007-0012-0
2. Safak A. A., Is M., Sevinc O., Barut C., Eryoruk N., Erdogmus B., Dosoglu M., The thickness of the ligamentum flavum in relation to age and gender. Clinical Anatomy 2010 23 1 79 83 2-s2.0-72249100142 10.1002/ca.20883
3. Abbas J., Hamoud K., Masharawi Y. M., May H., Hay O., Medlej B., Peled N., Hershkovitz I., Ligamentum flavum thickness in normal and stenotic lumbar spines. Spine 2010 35 12 1225 1230 2-s2.0-77953020040 10.1097/BRS. 0b013e3181bfca15
4. Szpalski M., Gunzburg R., Lumbar spinal stenosis in the elderly: an overview. European Spine Journal 2003 12 supplement 2 S170 S175 2-s2.0-0242657255 10.1007/s00586-003-0612-1
5. Viejo-Fuertes D., Liguoro D., Rivel J., Midy D., Guerin J., Morphologic and histologic study of the ligamentum flavum in the thoraco-lumbar region. Surgical and Radiologic Anatomy 1998 20 3 171 176 2-s2.0-0031821653
6. Kosaka H., Sairyo K., Biyani A., Leaman D., Yeasting R., Higashino K., Sakai T., Katoh S., Sano T., Goel V. K., Yasui N., Pathomechanism of loss of elasticity and hypertrophy of lumbar ligamentum flavum in elderly patients with lumbar spinal canal stenosis. Spine 2007 32 25 2805 2811 2-s2.0-39049089534 10.1097/BRS.0b013e31815b650f
7. Schräder P. K., Grob D., Rahn B. A., Cordey J., Dvorak J., Histology of the ligamentum flavum in patients with degenerative lumbar spinal stenosis. European Spine Journal 1999 8 4 323 328 2-s2.0-0032796374 10.1007/s005860050181
8. Oh I.-S., Ha K.-Y., Matrix metalloproteinase-3 on ligamentum flavum in degenerative lumbar spondylolisthesis. Spine 2009 34 16 E552 E557 2-s2.0-68949190591 10.1097/BRS.0b013e3181aa0232
9. Cui G., Watanabe K., Miyauchi Y., Hosogane N., Tsuji T., Ishii K., Nakamura M., Toyama Y., Chiba K., Miyamoto T., Matsumoto M., Matrix metalloproteinase 13 in the ligamentum flavum from lumbar spinal canal stenosis patients with and without diabetes mellitus. Journal of Orthopaedic Science 2011 16 6 785 790 2-s2.0-83055181403 10.1007/s00776-011-0135-2
10. Park J.-B., Kong C.-G., Suhl K.-H., Chang E.-D., Riew K. D., The increased expression of matrix metalloproteinases associated with elastin degradation and fibrosis of the ligamentum flavum in patients with lumbar spinal stenosis. Clinics in Orthopedic Surgery 2009 1 2 81 89 2-s2.0-79953776443
11. Park J.-B., Lee J.-K., Park S.-J., Riew K. D., Hypertrophy of ligamentum flavum in lumbar spinal stenosis associated with increased proteinase inhibitor concentration. Journal of Bone and Joint Surgery A 2005 87 12 I 2750 2757 2-s2.0-28544433018 10.2106/JBJS.E.00251
12. Zhang Y., Chen J., Zhong Z.-M., Yang D., Zhu Q., Is platelet-derived growth factor-BB expression proportional to fibrosis in the hypertrophied lumber ligamentum flavum? Spine 2010 35 25 E1479 1486 2-s2.0-79952277321
13. Zhong Z.-M., Zha D.-S., Xiao W.-D., Wu S.-H., Wu Q., Zhang Y., Liu F.-Q., Chen J.-T., Hypertrophy of ligamentum flavum in lumbar spine stenosis associated with the increased expression of connective tissue growth factor. Journal of Orthopaedic Research 2011 29 10 1592 1597 2-s2.0-80051549814 10.1002/jor.21431
14. Shafaq N., Suzuki A., Terai H., Wakitani S., Nakamura H., Cellularity and cartilage matrix increased in hypertrophied ligamentum flavum: histopathological analysis focusing on the mechanical stress and bone morphogenetic protein signaling. Journal of Spinal Disorders and Techniques 2012 25 2 107 115 2-s2.0-84859651978 10.1097/BSD.0b013e31820bb76e
15. Löhr M., Hampl J. A., Lee J. Y., Ernestus R.-I., Deckert M., Stenzel W., Hypertrophy of the lumbar ligamentum flavum is associated with inflammation-related TGF- β expression. Acta Neurochirurgica 2011 153 1 134 141 2-s2.0-78651250107 10.1007/s00701-010-0839-7
16. Sairyo K., Biyani A., Goel V. K., Leaman D. W., Booth R. Jr., Thomas J., Ebraheim N. A., Cowgill I. A., Mohan S. E., Lumbar ligamentum flavum hypertrophy is due to accumulation of inflammation-related scar tissue. Spine 2007 32 11 E340 E347 2-s2.0-34248332147 10.1097/01.brs.0000263407.25009.6e
17. Sairyo K., Biyani A., Goel V., Leaman D., Booth R. Jr., Thomas J., Gehling D., Vishnubhotla S. L., Long R., Ebraheim N., Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments. Spine 2005 30 23 2649 2656 2-s2.0-28844508615 10.1097/01.brs.0000188117.77657.ee
18. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5
19. Wang H.-Q., Yu X.-D., Liu Z.-H., Cheng X., Samartzis D., Jia L.-T., Wu S.-X., Huang J., Chen J., Luo Z.-J., Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. Journal of Pathology 2011 225 2 232 242 2-s2.0-80052460614 10.1002/path.2931
20. Jiang X., Tsitsiou E., Herrick S. E., Lindsay M. A., MicroRNAs and the regulation of fibrosis. FEBS Journal 2010 277 9 2015 2021 2-s2.0-77951219188 10.1111/j.1742-4658.2010.07632.x
21. Pandit K. V., Milosevic J., Kaminski N., MicroRNAs in idiopathic pulmonary fibrosis. Translational Research 2011 157 4 191 199 2-s2.0-79952790398 10.1016/j.trsl.2011.01.012
22. Tardif G., Hum D., Pelletier J.-P., Duval N., Martel-Pelletier J., Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskeletal Disorders 2009 10 1, article 148 2-s2.0-73649139221 10.1186/1471-2474-10-148
23. Miyaki S., Nakasa T., Otsuki S., Grogan S. P., Higashiyama R., Inoue A., Kato Y., Sato T., Lotz M. K., Asahara H., MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis and Rheumatism 2009 60 9 2723 2730 2-s2.0-69449103973 10.1002/art.24745
24. Stanczyk J., Leslie Pedrioli D. M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R. E., Detmar M., Gay S., Kyburz D., Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis and Rheumatism 2008 58 4 1001 1009 2-s2.0-42449156220 10.1002/art.23386
25. He J., Zhang F., Wu Y., Zhang W., Zhu X., He X., Zhao Y., Zhang W., Zhao Y., Prognostic role of microRNA-155 in various carcinomas: results from a meta-analysis. Disease Markers 2013 34 379 386 10.1155/2013/856750
26. Wang G., Kwan B. C.-H., Lai F. M.-M., Chow K.-M., Li P. K.-T., Szeto C.-C., Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Disease Markers 2011 30 4 171 179 2-s2.0-79959761647 10.3233/DMA-2011-0766
27. Sakamaki T., Sairyo K., Sakai T., Tamura T., Okada Y., Mikami H., Measurements of ligamentum flavum thickening at lumbar spine using MRI. Archives of Orthopaedic and Trauma Surgery 2009 129 10 1415 1419 2-s2.0-69249234635 10.1007/s00402-009-0849-1
28. Benoist M., Natural history of the aging spine. European Spine Journal 2003 12 2 S86 S89 2-s2.0-0242405493 10.1007/s00586-003-0593-0
29. Okuda T., Baba I., Fujimoto Y., Tanaka N., Sumida T., Manabe H., Hayashi Y., Ochi M., The pathology of ligamentum flavum in degenerative lumbar disease. Spine 2004 29 15 1689 1697 2-s2.0-3542998653 10.1097/01.BRS.0000132510.25378.8C
30. Bala S., Szabo G., MicroRNA signature in alcoholic liver disease. International Journal of Hepatology 2012 2012 6 498232 10.1155/2012/498232
31. Pogribny I. P., Starlard-Davenport A., Tryndyak V. P., Han T., Ross S. A., Rusyn I., Beland F. A., Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Laboratory Investigation 2010 90 10 1437 1446 2-s2.0-77957259450 10.1038/labinvest.2010.113
32. Bhattacharyya S., Balakathiresan N. S., Dalgard C., Gutti U., Armistead D., Jozwik C., Srivastava M., Pollard H. B., Biswas R., Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. Journal of Biological Chemistry 2011 286 13 11604 11615 2-s2.0-79953171192 10.1074/jbc.M110.198390
33. Kong W., Yang H., He L., Zhao J.-J., Coppola D., Dalton W. S., Cheng J. Q., MicroRNA-155 is regulated by the transforming growth factor β /Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Molecular and Cellular Biology 2008 28 22 6773 6784 2-s2.0-55849123946 10.1128/MCB.00941-08
34. Rai D., Kim S.-W., McKeller M. R., Dahia P. L. M., Aguiar R. C. T., Targeting of SMAD5 links microRNA-155 to the TGF- β pathway and lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 7 3111 3116 2-s2.0-77649242925 10.1073/pnas. 0910667107